from Reuters: Business News https://ift.tt/2OC5gJb
Monday, 1 April 2019
Novartis to pay $310 million for assets from inflammation specialist IFM
Novartis on Monday said it had agreed to pay $310 million upfront, with the possibility for more later, for some research assets of Boston-based inflammation specialist IFM Therapeutics as the Swiss drugmaker expands its immunology pipeline.
from Reuters: Business News https://ift.tt/2OC5gJb
from Reuters: Business News https://ift.tt/2OC5gJb
Subscribe to:
Post Comments (Atom)
3 takeaways from our Davos panel on the future of robotics
5 AI and trade experts at Davos share their thoughts on the future of Robotics. INA FASSBENDER / AFP via Getty Images Digital twins are...
-
Caroline Purser/Getty Images The S&P 500 has shed 4% since the beginning of the year as Big Tech stocks decline. However, previou...
-
AP Photo The Magnificent Seven stocks' dominance may soon fade, warns Glenmede Investment Management. Current market concentratio...
-
The Bell V-280 Valor was selected as the Army's future long-range assault aircraft in 2022. Photo courtesy of Bell The US Army desi...
No comments:
Post a Comment